Basic fibroblast growth factor accelerates wound healing in chronically ischaemic tissue
✍ Scribed by Dr E. Uhl; J. H. Barker; I. Bondàr; T. J. Galla; R. Leiderer; H.-A. Lehr; K. Messmer
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 517 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objectives: To evaluate basic fibroblast growth factor‐2 (BFGF) and hyaluronic acid (HA) effects on a surgically produced tracheal defect. ## Study Design: Animal model. ## Methods: Anterior punch lesions were created on 33 male rabbits divided into three equal groups. Group 1 (
## Abstract Recent advances in understanding the biology of fracture healing and the availability of specific macromolecules has resulted in the development of novel treatments for injuries to bone. Fibroblast growth factor‐2 or basic fibroblast growth factor (4 mg/ml), a potent mitogen, and hyalur
## Abstract Pain‐related neuropeptides released from synovial fibroblasts, such as substance P, have been implicated in joint destruction. Substance P‐induced inflammatory processes are mediated via signaling through a G‐protein‐coupled receptor, that is, neurokinin‐1 tachykinin receptor (NK~1~‐R).